News

Lung cancer (LC) is a major global health issue, with high mortality rates and limited therapeutic options. It is primarily categorized into non-small cell lung cancer (NSCLC) and small cell lung ...
Lung cancer (LC) is a major global health issue, with high mortality rates and limited therapeutic options. It is primarily categorized into non-small ...
Cancer is one of the leading causes of death worldwide, but what if simple lifestyle changes could significantly lower the ...
The "KRAS Inhibitors Market, Drug Sales, Patent, Price & Clinical Trials Insight 2030" report has been added to ResearchAndMarkets.com's offering. The global market for KRAS inhibitors has seen ...
Coffee or caffeine can alter circulating levels of sex hormone binding globulin, estrogen, C-peptide, and adiponectin. Coffee ...
MULGONET combines deep learning and multi-omics analysis to predict tumor recurrence, addressing interpretability and ...
A new study has identified a novel strategy for treating acute myelogenous leukemia (AML), an aggressive blood cancer for which the median survival time following diagnosis remains just 8.5 months.
A subset of patients with non-small cell lung cancer (NSCLC) who discontinued immune checkpoint inhibitor (ICI) therapy due ...